Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2
- 1 December 2004
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 82 (12), 1103-1112
- https://doi.org/10.1139/y04-121
Abstract
Activation of endothelial proteinase-activated receptor 2 (PAR-2) relaxes vascular smooth muscle (VSM) and causes hypotension by nitric oxide (NO)–prostanoid-dependent and -independent mechanisms. We investigated whether endothelium-dependent hyperpolarization of VSM was the mechanism whereby resistance caliber arteries vasodilated independently of NO. VSM membrane potentials and isometric tension were measured concurrently to correlate the electrophysiological and mechanical changes in murine small caliber mesenteric arteries. In uncontracted arteries, the PAR-2 agonist, SLIGRL-NH2(0.1 to 10 µmol/L), hyperpolarized the VSM membrane potential only in endothelium-intact arterial preparations. This response was unaltered by treatment of arteries with inhibitors of NO synthases (L-NAME), soluble guanylyl cyclase (ODQ), and cyclooxygenases (indomethacin). L-NAME, ODQ, and indomethacin also failed to inhibit SLIGRL-NH2-induced hyperpolarization and of cirazoline-contracted mesenteric arteries. However, in blood vessels that were depolarized and contracted with 30 mmol/L KCl, the effects of the SLIGRL-NH2on membrane potential and tension were not observed. SLIGRL-NH2-induced hyperpolarization and relaxation was inhibited completely by the combination of apamin plus charybdotoxin, but only partially inhibited after treatment with the combination of barium plus ouabain, suggesting an important role for SKCaand IKCachannels and a lesser role for Kirchannels and Na+/K+ATPases in the hyperpolarization response. We concluded that activation of endothelial PAR-2 hyperpolarized the vascular smooth muscle (VSM) cells of small caliber arteries, without requiring the activation of NO synthases, cyclooxygenases, or soluble guanylyl cyclase. Indeed, this hyperpolarization may be a primary mechanism for PAR-2–induced hypotension in vivo.Key words: proteinase-activated receptor 2, protease-activated receptor 2, endothelium, vascular smooth muscle, hyperpolarization, blood vessels, transgenic mice, vasoactive peptides.Keywords
This publication has 32 references indexed in Scilit:
- Catalase has negligible inhibitory effects on endothelium‐dependent relaxations in mouse isolated aorta and small mesenteric arteryBritish Journal of Pharmacology, 2003
- Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factorProceedings of the National Academy of Sciences, 2003
- Essential role for proteinase-activated receptor-2 in arthritisJournal of Clinical Investigation, 2003
- Induction of Intestinal Inflammation in Mouse by Activation of Proteinase-Activated Receptor-2The American Journal of Pathology, 2002
- Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aortaCanadian Journal of Physiology and Pharmacology, 2002
- EDHF: bringing the concepts togetherTrends in Pharmacological Sciences, 2002
- cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctionsProceedings of the National Academy of Sciences, 2002
- Protease activated receptor 2 and the cardiovascular systemBritish Journal of Pharmacology, 2002
- Potassium‐ and acetylcholine‐induced vasorelaxation in mice lacking endothelial nitric oxide synthaseBritish Journal of Pharmacology, 2000
- K+ is an endothelium-derived hyperpolarizing factor in rat arteriesNature, 1998